Navigation Links
Nutraceutical Reports 2007 Fiscal Year End Results
Date:11/29/2007

>

Basic 11,136,702 11,179,554 11,054,828 11,332,466

Diluted 11,307,910 11,363,751 11,253,283 11,517,492

NUTRACEUTICAL INTERNATIONAL CORPORATION

ADJUSTED EBITDA SCHEDULE

(unaudited; dollars in thousands)

Three months Twelve months

ended September 30, ended September 30,

2007 2006 2007 2006

Net income $2,605 $3,086 $12,972 $14,940

Provision for income taxes 1,597 1,933 7,951 9,353

Interest and other (income)/expense,

net (1)(2) 443 136 1,257 (757)

Depreciation and amortization 1,292 1,051 4,793 4,527

Impairment of intangible asset (3) 450 - 450 -

Adjusted EBITDA $6,387 $6,206 $27,423 $28,063

(1) Includes amortization of deferred financing fees and losses associated

with fixed asset disposals.

(2) Includes other income of $1,105 for the twelve months ended

September 30, 2006 related to a gain on the sale of a building.

(3) A non-cash intangible asset impairment charge of $450 related to the

re-branding of certain health food stores was recorded for the three

months and twelve months ended September 30, 2007.


'/>"/>
SOURCE Nutraceutical International Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. New Nutraceutical That Stabilizes Blood Sugar Naturally is Introduced
2. New Nutraceutical Supplement Provides Simplified Approach to Diabetes Management Programs
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009).../ -- Allscripts-Misys Healthcare,Solutions, Inc.,...llscripts or,the Company), today announced its fi...d November 30, 2008. , (Logo: http://www.n...) , The Company,s results for the three and...ts from legacy Allscripts for the period of Octobe...
(Date:1/8/2009).../ -- The Pew Charitable Trusts announced today tha...and food safety programs, in its Health & Huma... deputy staff director and general counsel of the ...brings nearly 25 years of experience in environmen...We are excited to be joined by such an experienced...
(Date:1/8/2009)...ine Siu and Jason Brown, Ph.D. Promoted to Vice Pr...FORD, Conn., Jan. 8 Thomas, McNern...irm that invests in life science and medical techn...three members of its investment team. Kathy Tune ... Jason Brown have been promoted to Vice President....
(Date:1/8/2009)...re/ -- A proposal by the State of Indiana to close...has prompted the 125,000-member American Legion De...r conference January 10-12, 2009, in order to orga...opposition to the proposal. , , The Legion, whi...nd in-kind support to the home, is among the forem...
Breaking Medicine News(10 mins):Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Thomas, McNerney & Partners Promotes Three Members of Its Investment Team 2
...ound 10 million female fetuses may have been abort...ng to a study published online today by The Lancet...heir study Prabhat Jha (St. Michael's Hospital, Un...ar (Post-Graduate Institute of Medical Education a...
...ltimore has been named America's fittest city by M...st. According to the ranking accorded by the Men's... Baltimore were Honolulu, Virginia Beach, Va., Tuc...test cities behind Chicago were Las Vegas, Los Ang...
...inese Minister of Health Gao Qiang said China has ...cies, both treatment and prevention. // The SARS ...emic disease prevention and control system. The go...ps to address them, he said. After 27 billion yuan...
... least five people-three in Ankara and two in Van-... the bird flu virus, a Turkish official said on Su... of the health ministry's Basic Health Services, t...28 people were tested at a government laboratory i...
Other Medicine News:Health News:10 Million Indian Females Aborted In 20 years 2
(Date:1/7/2009)...wire/ -- Circassia Ltd, a specialty,biopharmaceut... today,announced that following successful clinic...) anti-allergy technology, the company has now com... clinical trial in cat allergy. The,study, which ...with confirmed,cat allergies, and all the partici...
(Date:1/6/2009)...ining a healthy immune system , , PURCHASE, N.Y...dy in Nutrition and Cancer (60(5), 643-651) by r...Japan has shown that AHCC (Active Hexose Correlate... the number of dendritic cells (DCs). DCs are a ke...ting foreign substances to other immune system cel...
(Date:1/6/2009)...e/ -- The Michael J. Fox Foundation awarded a tota...teams for pre-clinical research on potential new t...ing was awarded under the Foundation,s Therapeuti...unched in 2006, supports and bolsters industry-foc...t of MJFF,s focus on ,de-risking, preclinical PD...
(Date:1/6/2009)...-- Cequent Pharmaceuticals, a pioneer in the devel...atments to prevent and treat human disease, announ...essful toxicology study of its candidate CEQ501, a...ng the primary oncogene (beta-catenin, CTNNB1) in ...herited gastrointestinal disease that causes hundr...
Breaking Medicine Technology:Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3AAP National Conference and Exhibition October 10 14 2008 27161 1AAP National Conference and Exhibition October 10 14 2008 27161 2AAP National Conference and Exhibition October 10 14 2008 27161 3RAI to Webcast Third Quarter 2008 Earnings Conference Call 27157 1RAI to Webcast Third Quarter 2008 Earnings Conference Call 27157 2Video 3A Answer to Curing a Failing Heart May Exist in Bodys Own Do It Yourself Repair Kit 3254 1Video 3A Answer to Curing a Failing Heart May Exist in Bodys Own Do It Yourself Repair Kit 3254 2Video 3A Answer to Curing a Failing Heart May Exist in Bodys Own Do It Yourself Repair Kit 3254 3Scripps research team solves structure of beneficial virus 5287 1Scripps research team solves structure of beneficial virus 5287 2
Inquiry H Steerable Catheter. Steerable atrial mapping catheter offers a variety of designs and a unique 45 offset for catheter stability. 10 to 24 electrodes, regular and large steerable curves, ina
A steerable diagnostic catheter with optimal maneuverability
For Atrial Isthmus Mapping. Biosense Webster offers a complete line of specialty 20-pole catheters. The SANTORO Fixed Catheter is designed for simple subclavian access and placement in the coronary s
Standard Deflectable Catheters
Medicine Products: